Type II Diabetes II: Pathophysiology
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Diabetes Mellitus: Overview and Type I Subtype
Type I Diabetes II: Pathophysiology
Type I Diabetes III: Clinical Manifestations
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 16, 2026

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)
Published on: January 7, 2018
Matthias Blüher1,2, Jörg Bojunga3, Martin Fassnacht4
1Helmholtz-Institut für Metabolismus‑, Adipositas- und Gefäßforschung (HI-MAG), Helmholtz Zentrum München an der Universität Leipzig und dem Universitätsklinikum Leipzig AöR, Leipzig, Deutschland.
Personalized therapies for endocrine and metabolic disorders are advancing, particularly in obesity with new incretin-based treatments. Management of adrenal incidentalomas, hypertension, and thyroid cancer is also shifting towards risk-adapted approaches for better outcomes.
Area of Science: